Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Scudla

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
Vnitrni Lekarstvi|April 1, 1991
[Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis]V Scudla, M Budíková, E Fischerová, et al.
Casopis Lekaru Ceskych|November 20, 1996
[Soluble interleukin-6 receptors in the serum in multiple myeloma]V Scudla, D Kubalová, J Bacovský, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levelsV Scudla, M Budíková, E Fischerová, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease]V Scudla, J Bacovský, T Papajík, et al.
Vnitrni Lekarstvi|May 28, 1998
[The autoantibody profile and disease activity in patients with systemic lupus erythematosus]P Horák, Z Hermanová, L Faltýnek, et al.
Cancer Genetics and Cytogenetics|September 1, 1996
Two cases of t(9;20) in multiple myelomaM Jarosová, V Scudla, Bacovský, et al.
Vnitrni Lekarstvi|May 1, 1997
[Vascular intercellular adhesive molecule-1 (VCAM-1)--a new indicator of activity in systemic lupus erythematosus?]V Scudla, P Horák, L Faltýnek, et al.
Vnitrni Lekarstvi|October 25, 2000
[Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. I. Relation to selected laboratory indicators of the disease]V Scudla, M Ordeltová, A Spidlová, et al.
Vnitrni Lekarstvi|August 1, 1994
[Clinical importance of the paraprotein index in multiple myeloma]T Papajík, J Bacovský, J Zadrazil, et al.
Vnitrni Lekarstvi|April 1, 1991
[The iron reserve status in patients on regular dialysis treatment]J Zadrazil, T Papajík, V Scudla, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
Vnitrni Lekarstvi|April 1, 1991
[Serum beta 2-microglobulin in multiple myeloma. I. Relation to selected indicators, clinical stage and disease prognosis]V Scudla, M Budíková, E Fischerová, et al.
Casopis Lekaru Ceskych|November 20, 1996
[Soluble interleukin-6 receptors in the serum in multiple myeloma]V Scudla, D Kubalová, J Bacovský, et al.
Acta Universitatis Palackianae Olomucensis Facultatis Medicae|January 1, 1991
Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levelsV Scudla, M Budíková, E Fischerová, et al.
Vnitrni Lekarstvi|March 1, 1994
[Serum thymidine kinase in multiple myeloma: I. Relation to selected laboratory indicators in the disease]V Scudla, J Bacovský, T Papajík, et al.
Vnitrni Lekarstvi|May 28, 1998
[The autoantibody profile and disease activity in patients with systemic lupus erythematosus]P Horák, Z Hermanová, L Faltýnek, et al.
Cancer Genetics and Cytogenetics|September 1, 1996
Two cases of t(9;20) in multiple myelomaM Jarosová, V Scudla, Bacovský, et al.
Vnitrni Lekarstvi|May 1, 1997
[Vascular intercellular adhesive molecule-1 (VCAM-1)--a new indicator of activity in systemic lupus erythematosus?]V Scudla, P Horák, L Faltýnek, et al.
Vnitrni Lekarstvi|October 25, 2000
[Importance of determining the propidium-iodide index of plasmacytes in multiple myeloma. I. Relation to selected laboratory indicators of the disease]V Scudla, M Ordeltová, A Spidlová, et al.
Vnitrni Lekarstvi|August 1, 1994
[Clinical importance of the paraprotein index in multiple myeloma]T Papajík, J Bacovský, J Zadrazil, et al.
Vnitrni Lekarstvi|April 1, 1991
[The iron reserve status in patients on regular dialysis treatment]J Zadrazil, T Papajík, V Scudla, et al.
Pageof 8